← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:613 | 613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7009 | 71285-7009-1 | Heparin Sodium | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:613 | 613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-104 | 71449-104-11 | Glycopyrrolate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:613 | 613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:613 | 613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6381 | 72934-6381-2 | Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:613 | 613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Cyanocobalamin; Pyridoxine Hydrochloride; Methionine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:613 | 613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-3 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:613 | 613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:614 | 614 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-663 | 70092-663-43 | Lido 1%-epi 10mcg/ml (Buff) 3ml NaCl syr | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:614 | 614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-027 | 71591-027-01 | Doxycycline | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:614 | 614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:614 | 614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6440 | 71300-6440-2 | Gabapentin | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:614 | 614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluoxetine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:614 | 614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:614 | 614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:614 | 614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:614 | 614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2012 | 71286-2012-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:614 | 614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:614 | 614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:614 | 614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-113 | 70092-113-79 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:614 | 614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6392 | 72934-6392-2 | Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:614 | 614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:614 | 614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-4 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:614 | 614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:615 | 615 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0428 | 72196-0428-1 | Trophamine 3% / Dextrose 10% With Calcium Gluconate 2.33mEq and Heparin 125 units 250ml in 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:615 | 615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-026 | 71591-026-01 | Doxycycline Anhydrous | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:615 | 615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:615 | 615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:615 | 615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluoxetine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:615 | 615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-05 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:615 | 615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:615 | 615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:615 | 615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-3 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:615 | 615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0429 | 72196-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:615 | 615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-9 | Glycopyrrolate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:615 | 615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-111 | 70092-111-48 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:615 | 615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6382 | 72934-6382-2 | Hydroquinone; Tretinoin | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:615 | 615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:615 | 615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:615 | 615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:616 | 616 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1225 | 73271-1225-1 | TESTOSTERONE CYPIONATE 200 MG/ML MIGLYOL 812N 5ML NDC 73271-1225-1 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:616 | 616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Doxycycline Hyclate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:616 | 616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-526 | 69374-526-20 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:616 | 616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:616 | 616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Flurbiprofen | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:616 | 616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-02 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:616 | 616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:616 | 616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:616 | 616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-2 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:616 | 616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:616 | 616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycopyrrolate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:616 | 616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5035 | 71266-5035-1 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:616 | 616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6388 | 72934-6388-2 | Hydroquinone; Tretinoin; Hydrocortisone | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:616 | 616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:616 | 616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:616 | 616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:617 | 617 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2535 | 72934-2535-4 | Nolira | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:617 | 617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-023 | 71591-023-01 | Doxycycline Hyclate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:617 | 617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:617 | 617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:617 | 617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fomepizole | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:617 | 617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-03 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:617 | 617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:617 | 617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:617 | 617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:617 | 617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:617 | 617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-3 | Glycopyrrolate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:617 | 617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:617 | 617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:617 | 617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride; Levocarnitine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:617 | 617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-563 | 70092-563-43 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:617 | 617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0007 | 81483-0007-2 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:618 | 618 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-7536 | 83863-7536-1 | Succinylcholine Chloride 100 mg in 5 mL (20 mg/mL) | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:618 | 618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-022 | 71591-022-01 | Doxycycline Hyclate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:618 | 618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-4272 | 60652-4272-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:618 | 618 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:618 | 618 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:618 | 618 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:618 | 618 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:618 | 618 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Ascorbic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:618 | 618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-559 | 69374-559-30 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:618 | 618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:618 | 618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-5 | Glycopyrrolate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:618 | 618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5055 | 71266-5055-2 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:618 | 618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1435 | 72934-1435-2 | Ibuprofen; Salicylic Acid | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:618 | 618 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride; Levocarnitine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:618 | 618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-069 | 71449-069-32 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:618 | 618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0007 | 81483-0007-0 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:619 | 619 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2535 | 72934-2535-2 | Nolira | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:619 | 619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-024 | 71591-024-01 | Doxycycline Hyclate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:619 | 619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:619 | 619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:619 | 619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:619 | 619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:619 | 619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:619 | 619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Ascorbic Acid; Hydrocortisone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:619 | 619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-559 | 69374-559-50 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:619 | 619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:619 | 619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-32 | Glycopyrrolate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:619 | 619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:619 | 619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4235 | 72934-4235-9 | Ibuprofen; Terbinafine Hydrochloride; Fluconazole; Itraconazole | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:619 | 619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6487 | 71266-6487-5 | Iohexol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:619 | 619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-050 | 71170-050-05 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:619 | 619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0006 | 81483-0006-0 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:620 | 620 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2427 | 72627-2427-1 | Thiamine HCl/Riboflavin-5 Phosphate Sodium/Niacinamide/Dexpanthenol/Pyridoxine HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-028 | 71591-028-01 | Doxycycline Hyclate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:620 | 620 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:620 | 620 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:620 | 620 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5060 | 71266-5060-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-02 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:620 | 620 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Fluocinolone Acetonide; Tretinoin | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0600 | 60652-0600-2 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-1 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-109 | 73702-109-15 | Glycopyrrolate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6379 | 72934-6379-2 | Hydroquinone | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:620 | 620 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Cyanocobalamin; Pyridoxine Hydrochloride; Methionine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6488 | 71266-6488-3 | Iohexol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:620 | 620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-4001 | 72627-4001-2 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:621 | 621 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5608 | 26436-5608-3 | SEMAGLUTIDE | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:621 | 621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Doxycycline Hyclate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:621 | 621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-031 | 71591-031-01 | Fluconazole | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:621 | 621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:621 | 621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:621 | 621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-2 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:621 | 621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:621 | 621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Hydrocortisone; Tretinoin | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:621 | 621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-50 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:621 | 621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:621 | 621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:621 | 621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6383 | 72934-6383-2 | Hydroquinone | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:621 | 621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:621 | 621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0413 | 71285-0413-1 | Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Dextrose Monohydrate; Histidine; Arginine; Taurine; Leucine; Methionine; Proline; Aspartic Acid | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:621 | 621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-069 | 71449-069-11 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:621 | 621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-120 | 70092-120-43 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:622 | 622 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5608 | 26436-5608-2 | SEMAGLUTIDE | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5150 | 26436-5150-1 | Doxycycline Hyclate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-030 | 71591-030-01 | Fluconazole | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1566 | 5446-1566-50 | Gemcitabine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6440 | 71300-6440-2 | Gabapentin | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9170 | 71266-9170-5 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:622 | 622 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:622 | 622 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Hydrocortisone; Tretinoin; Ascorbic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-30 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-114 | 70092-114-50 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:622 | 622 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6390 | 72934-6390-2 | Hydroquinone | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:622 | 622 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 80098-030 | 80098-030-90 | Isosulfan Blue | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:622 | 622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-050 | 71170-050-05 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:623 | 623 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6006 | 72196-6006-1 | Lidocaine 2% | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:623 | 623 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Droperidol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:623 | 623 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-032 | 71591-032-01 | Fluconazole | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:623 | 623 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8029 | 71285-8029-1 | Glutamic Acid; Aspartic Acid | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:623 | 623 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1566 | 5446-1566-50 | Gemcitabine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:623 | 623 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:623 | 623 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:623 | 623 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Hydrocortisone; Tretinoin; Ascorbic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:623 | 623 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:623 | 623 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-116 | 70092-116-75 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:623 | 623 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:623 | 623 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6372 | 72934-6372-2 | Hydroquinone | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:623 | 623 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:623 | 623 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1531 | 72934-1531-2 | Ivermectin; Metronidazole | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:623 | 623 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:623 | 623 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-074 | 71506-074-05 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:624 | 624 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 85974-110 | 85974-110-13 | MaxMist 4% | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:624 | 624 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Droperidol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:624 | 624 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluocinonide; Hydroquinone; Tretinoin | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:624 | 624 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0402 | 71285-0402-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:624 | 624 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8029 | 71285-8029-1 | Glutamic Acid; Aspartic Acid | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:624 | 624 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:624 | 624 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:624 | 624 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Hydrocortisone; Tretinoin; Ascorbic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:624 | 624 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:624 | 624 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:624 | 624 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8100 | 72196-8100-1 | Heparin Sodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:624 | 624 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6371 | 72934-6371-2 | Hydroquinone | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:624 | 624 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:624 | 624 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:624 | 624 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-119 | 70092-119-44 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:624 | 624 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-050 | 71506-050-56 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:625 | 625 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-045 | 70713-045-01 | TESTOSTERONE C 87.5MG | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:625 | 625 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Droperidol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:625 | 625 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluoxetine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:625 | 625 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0404 | 71285-0404-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:625 | 625 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0428 | 71285-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Aspartic Acid; Leucine; Methionine; Proline; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:625 | 625 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:625 | 625 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:625 | 625 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroquinone; Tretinoin; Dexamethasone | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:625 | 625 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-117 | 70092-117-79 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:625 | 625 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-30 | Hydromorphone Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:625 | 625 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-281 | 70092-281-08 | Heparin Sodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:625 | 625 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6387 | 72934-6387-2 | Hydroquinone; Hydrocortisone; Tretinoin | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:625 | 625 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Choline Chloride; Levocarnitine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:625 | 625 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-11 | Ketamine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:625 | 625 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:625 | 625 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2503 | 72934-2503-2 | Ketoconazole; Hydrocortisone | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:626 | 626 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-302 | 82396-302-04 | Semaglutide | 2025-1 | valid | 0 | 2026-09-18 |